Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C H Schwalbe

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Anti-Cancer Drug Design|August 1, 1988
The geometry of N-hydroxymethyl compounds. Part 2: Crystal structures of 1-(4-carbethoxyphenyl)-3-hydroxymethyl-3-methyltriazene, N-hydroxymethylpentamethylmelamine and N-hydroxymethylbenzamideR J Simmonds, E B Katenga, C H Schwalbe
The Biochemical Journal|May 1, 1980
Crystallographic and molecular-orbital studies on the geometry of antifolate drugsW E Hunt, C H Schwalbe, K Bird, et al.
Biochemical Society Transactions|October 1, 1990
Active-site modelling of class I beta-lactamasesC A Toomer, P A Lambert, C E Sansom, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|July 21, 2004
A new amidrazone derivative with antimycobacterial activityD C Billington, P R Lowe, D L Rathbone, et al.
Journal of Medicinal Chemistry|November 1, 1989
Structural studies on bioactive compounds. 8. Synthesis, crystal structure, and biological properties of a new series of 2,4-diamino-5-aryl-6-ethylpyrimidine dihydrofolate reductase inhibitors with in vivo activity against a methotrexate-resistant tumor cell lineR J Griffin, M A Meek, C H Schwalbe, et al.
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|September 11, 2003
X-ray crystallographic and theoretical studies of an anticonvulsant enaminone: methyl 4-(4'-bromophenyl)amino-6-methyl-2-oxocyclohex-3-en-1-oateI O Edafiogho, B J Denny, C H Schwalbe, et al.
Anti-Cancer Drug Design|February 1, 1990
Anti-tumour imidazotetrazines. Part XXI. Mitozolomide and temozolomide: probes for the major groove of DNAA S Clark, M F Stevens, C E Sansom, et al.
Anti-Cancer Drug Design|April 1, 1995
Structural studies on bioactive compounds. Part 26. Hydrogen bonding in the crystal structure of the N-methylformamide solvate of the immunomodulatory agent 2-amino-5-bromo-6-phenylpyrimidin-4-one (bropirimine): implications for the design of novel anti-tumour strategiesM F Stevens, C H Schwalbe, N Patel, et al.
Nature: New Biology|December 12, 1973
X-ray study of helix, loop and base pair stacking in trinucleoside diphosphate ApApAD Suck, P C Manor, G Germain, et al.
Anti-Cancer Drug Design|August 1, 1990
Structural studies on bio-active compounds. Part XIV. Molecular modelling of the interactions between pentamidine and DNAC E Sansom, C A Laughton, S Neidle, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Anti-Cancer Drug Design|August 1, 1988
The geometry of N-hydroxymethyl compounds. Part 2: Crystal structures of 1-(4-carbethoxyphenyl)-3-hydroxymethyl-3-methyltriazene, N-hydroxymethylpentamethylmelamine and N-hydroxymethylbenzamideR J Simmonds, E B Katenga, C H Schwalbe
The Biochemical Journal|May 1, 1980
Crystallographic and molecular-orbital studies on the geometry of antifolate drugsW E Hunt, C H Schwalbe, K Bird, et al.
Biochemical Society Transactions|October 1, 1990
Active-site modelling of class I beta-lactamasesC A Toomer, P A Lambert, C E Sansom, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|July 21, 2004
A new amidrazone derivative with antimycobacterial activityD C Billington, P R Lowe, D L Rathbone, et al.
Journal of Medicinal Chemistry|November 1, 1989
Structural studies on bioactive compounds. 8. Synthesis, crystal structure, and biological properties of a new series of 2,4-diamino-5-aryl-6-ethylpyrimidine dihydrofolate reductase inhibitors with in vivo activity against a methotrexate-resistant tumor cell lineR J Griffin, M A Meek, C H Schwalbe, et al.
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|September 11, 2003
X-ray crystallographic and theoretical studies of an anticonvulsant enaminone: methyl 4-(4'-bromophenyl)amino-6-methyl-2-oxocyclohex-3-en-1-oateI O Edafiogho, B J Denny, C H Schwalbe, et al.
Anti-Cancer Drug Design|February 1, 1990
Anti-tumour imidazotetrazines. Part XXI. Mitozolomide and temozolomide: probes for the major groove of DNAA S Clark, M F Stevens, C E Sansom, et al.
Anti-Cancer Drug Design|April 1, 1995
Structural studies on bioactive compounds. Part 26. Hydrogen bonding in the crystal structure of the N-methylformamide solvate of the immunomodulatory agent 2-amino-5-bromo-6-phenylpyrimidin-4-one (bropirimine): implications for the design of novel anti-tumour strategiesM F Stevens, C H Schwalbe, N Patel, et al.
Nature: New Biology|December 12, 1973
X-ray study of helix, loop and base pair stacking in trinucleoside diphosphate ApApAD Suck, P C Manor, G Germain, et al.
Anti-Cancer Drug Design|August 1, 1990
Structural studies on bio-active compounds. Part XIV. Molecular modelling of the interactions between pentamidine and DNAC E Sansom, C A Laughton, S Neidle, et al.
Pageof 3